Circulating soluble Fas ligand in patients with gastric carcinoma

Cancer

Volumn 89, Issue 12, 2000, Pages 2560-2564

  Tsutsumi, Souichi ^a   Kuwano, Hiroyuki ^a   Shimura, Tatsuo ^a   Morinaga, Nobuhiro ^a   Mochiki, Erito ^a   Asao, Takayuki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Cutoff value; Gastric carcinoma; Immune privilege; SFasL

Indexed keywords

FAS LIGAND; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; STOMACH CARCINOMA; SURVIVAL RATE;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SOLUBILITY; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0034672086     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20001215)89:12<2560::AID-CNCR7>3.0.CO;2-Q     Document Type: Article

References (23)

1. Expression of the Fas ligand in cells of T cell lineage
2. Fas-mediated cytotoxity by freshly isolated natural killer cells
3. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
4. Fas ligand-induced apoptosis as a mechanism of immune privilege
5. A role for CD95 ligand in preventing graft rejection
6. Expression of Fas ligand by human cytotrophoblasts: Implication in placentation and fetal survival
7. Melanoma cell expression of Fas (Apo-1/ CD95) ligand: Implications for tumor immune escape
8. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
9. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells-a mechanism of immune evasion?
10. Human lung carcinoma express Fas ligand
11. Fas ligand expressing by astrocytoma in vivo: Maintaining immune privilege in the brain
12. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells
13. Expression of Fas ligand in liver metastasis of human colonic adenocarcinoma
14. Metalloproteinase-mediated release of human Fas ligand
15. Expression of the functional soluble form of human Fas ligand in activated lymphocytes
16. Fas ligand in human serum
17. Elevated serum soluble Fas ligand in natural killer cell proliferative disorders
18. Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy
19. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: How do hepatoma cells escape from the host immune surveillance in vivo?
20. Levels of soluble FasL and FasL gene expression during the development of graft-versus-host disease in DLT-treated patients
21. Expression of Fas ligand by human gastric adenocarcinoma: A potential mechanism of immune escape in stomach cancer
22. The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens